{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:27:14Z","timestamp":1793935634761,"version":"4.8.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"FI2","license":[{"start":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T00:00:00Z","timestamp":1508198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Sydney Medical School Foundation Fellowship"},{"DOI":"10.13039\/100004329","name":"Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Biomedical Research Unit"},{"name":"Centres at Barts and University College London Hospitals"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9,1]]},"DOI":"10.1093\/europace\/eux261","type":"journal-article","created":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T10:28:32Z","timestamp":1508236112000},"page":"f153-f161","source":"Crossref","is-referenced-by-count":116,"title":["Ventricular arrhythmia and sudden cardiac death in Fabry disease: a systematic review of risk factors in clinical practice"],"prefix":"10.1093","volume":"20","author":[{"given":"Shanat","family":"Baig","sequence":"first","affiliation":[{"name":"Department of Cardiology, First Floor, Nuffield House, Queen Elizabeth Hospital, Edgbaston, Birmingham, UK"},{"name":"Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicky C","family":"Edward","sequence":"additional","affiliation":[{"name":"Department of Cardiology, First Floor, Nuffield House, Queen Elizabeth Hospital, Edgbaston, Birmingham, UK"},{"name":"Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipak","family":"Kotecha","sequence":"additional","affiliation":[{"name":"Department of Cardiology, First Floor, Nuffield House, Queen Elizabeth Hospital, Edgbaston, Birmingham, UK"},{"name":"Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, First Floor, Nuffield House, Queen Elizabeth Hospital, Edgbaston, Birmingham, UK"},{"name":"Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Nordin","sequence":"additional","affiliation":[{"name":"Barts Heart Centre, London, UK"},{"name":"Institute of Cardiovascular Science, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Kozor","sequence":"additional","affiliation":[{"name":"Sydney Medical School, University of Sydney, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C","family":"Moon","sequence":"additional","affiliation":[{"name":"Barts Heart Centre, London, UK"},{"name":"Institute of Cardiovascular Science, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarekegn","family":"Geberhiwot","sequence":"additional","affiliation":[{"name":"Centre for Rare Diseases, Queen Elizabeth Hospital Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P","family":"Steeds","sequence":"additional","affiliation":[{"name":"Department of Cardiology, First Floor, Nuffield House, Queen Elizabeth Hospital, Edgbaston, Birmingham, UK"},{"name":"Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,10,17]]},"reference":[{"key":"key\n\t\t\t\t20180914094344_eux261-B1","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM196705252762101","article-title":"Enzymatic defect in Fabry\u2019s disease: ceramide-trihexosidase deficiency","volume":"276","author":"Brady","year":"1967","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180914094344_eux261-B2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/GIM.0b013e31802d8321","article-title":"Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life","volume":"9","author":"Wang","year":"2007","journal-title":"Genet Med"},{"key":"key\n\t\t\t\t20180914094344_eux261-B3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/08035320600618809","article-title":"Disease manifestations and \u00d7 inactivation in heterozygous females with Fabry disease","volume":"95","author":"Maier","year":"2006","journal-title":"Acta Paediatr"},{"key":"key\n\t\t\t\t20180914094344_eux261-B4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ymgme.2007.09.013","article-title":"Females with Fabry disease frequently have major organ involvement: lessons from the Fabry registry","volume":"93","author":"Wilcox","year":"2008","journal-title":"Mol Genet Metab"},{"key":"key\n\t\t\t\t20180914094344_eux261-B5","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/eurheartj\/ehm153","article-title":"Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey","volume":"28","author":"Linhart","year":"2007","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180914094344_eux261-B6","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/GIM.0b013e3181bb05bb","article-title":"Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry registry","volume":"11","author":"Waldek","year":"2009","journal-title":"Genet Med"},{"key":"key\n\t\t\t\t20180914094344_eux261-B7","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/jmg.2008.065904","article-title":"Natural course of Fabry disease: changing pattern of causes of death in FOS\u2014Fabry outcome survey","volume":"46","author":"Mehta","year":"2009","journal-title":"J Med Genet"},{"key":"key\n\t\t\t\t20180914094344_eux261-B8","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/CIRCEP.114.002569","article-title":"Pathology and function of conduction tissue in Fabry disease cardiomyopathy","volume":"8","author":"Frustaci","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"key\n\t\t\t\t20180914094344_eux261-B9","first-page":"1601","article-title":"ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"17","author":"Priori","year":"2015","journal-title":"Europace"},{"key":"key\n\t\t\t\t20180914094344_eux261-B10","doi-asserted-by":"crossref","first-page":"e1000097.","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20180914094344_eux261-B11","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.amjcard.2005.05.033","article-title":"Prevalence and clinical significance of cardiac arrhythmia in Anderson-Fabry disease","volume":"96","author":"Shah","year":"2005","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20180914094344_eux261-B12","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.amjcard.2014.06.019","article-title":"Relation of burden of myocardial fibrosis to malignant ventricular arrhythmias and outcomes in Fabry disease","volume":"114","author":"Kr\u00e4mer","year":"2014","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20180914094344_eux261-B13","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/clc.22047","article-title":"Arrhythmias in Fabry cardiomyopathy","volume":"35","author":"Acharya","year":"2012","journal-title":"Clin Cardiol"},{"key":"key\n\t\t\t\t20180914094344_eux261-B14","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/heartjnl-2014-306782","article-title":"Clinical and genetic predictors of major cardiac events in patients with Anderson-Fabry disease","volume":"101","author":"Patel","year":"2015","journal-title":"Heart"},{"key":"key\n\t\t\t\t20180914094344_eux261-B15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/joim.12077","article-title":"Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications","volume":"274","author":"Weidemann","year":"2013","journal-title":"J Intern Med"},{"key":"key\n\t\t\t\t20180914094344_eux261-B16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.amjcard.2016.04.033","article-title":"Usefulness of an implantable loop recorder to detect clinically relevant arrhythmias in patients with advanced Fabry cardiomyopathy","volume":"118","author":"Weidemann","year":"2016","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20180914094344_eux261-B17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1136\/heartjnl-2014-306278","article-title":"Cardiovascular outcomes in Fabry disease are linked to severity of chronic kidney disease","volume":"101","author":"Talbot","year":"2015","journal-title":"Heart"},{"key":"key\n\t\t\t\t20180914094344_eux261-B18","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s10545-011-9428-z","article-title":"Increased arterial stiffness is associated with high cardiovascular mortality in male Fabry patients","volume":"35","author":"Nicholls","year":"2012","journal-title":"J Inherit Metab Dis"},{"key":"key\n\t\t\t\t20180914094344_eux261-B19","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/j.ymgme.2015.12.420","article-title":"Looking for predictors of mortality in patients with Fabry disease on enzyme replacement therapy","volume":"117","author":"Reisin","year":"2016","journal-title":"Mol Genet Metab"},{"key":"key\n\t\t\t\t20180914094344_eux261-B20","doi-asserted-by":"crossref","first-page":"14.","DOI":"10.1186\/s12968-016-0233-6","article-title":"Cardiovascular magnetic resonance demonstration of the spectrum of morphological phenotypes and patterns of myocardial scarring in Anderson-Fabry disease","volume":"18","author":"Deva","year":"2016","journal-title":"J Cardiovasc Magn Reson"},{"key":"key\n\t\t\t\t20180914094344_eux261-B21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/europace\/eup431","article-title":"Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers","volume":"12","author":"Christiaans","year":"2010","journal-title":"Europace"},{"key":"key\n\t\t\t\t20180914094344_eux261-B22","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1161\/CIRCULATIONAHA.110.976092","article-title":"Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop","volume":"122","author":"Fishman","year":"2010","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180914094344_eux261-B23","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.ehj.2003.09.017","article-title":"Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease evidence for a disease specific abnormality of the myocardial interstitium","volume":"24","author":"Moon","year":"2003","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180914094344_eux261-B24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jjcc.2007.12.001","article-title":"Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study","volume":"51","author":"Takenaka","year":"2008","journal-title":"J Cardiol"},{"key":"key\n\t\t\t\t20180914094344_eux261-B25","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.hrthm.2014.01.014","article-title":"Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy","volume":"11","author":"Perazzolo Marra","year":"2014","journal-title":"Heart Rhythm"},{"key":"key\n\t\t\t\t20180914094344_eux261-B26","doi-asserted-by":"crossref","first-page":"1.","DOI":"10.1186\/1471-2261-14-110","article-title":"Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study","volume":"14","author":"P\u00f6yh\u00f6nen","year":"2014","journal-title":"BMC Cardiovasc Disord"},{"key":"key\n\t\t\t\t20180914094344_eux261-B27","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180914094344_eux261-B28","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12882-016-0293-8","article-title":"Incidence of sudden cardiac death in adults with end-stage renal disease: a systematic review and meta-analysis","volume":"17","author":"Ramesh","year":"2016","journal-title":"BMC Nephrol"},{"key":"key\n\t\t\t\t20180914094344_eux261-B29","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.medcli.2014.01.032","article-title":"Comprehensive clinical evaluation of a large Spanish family with Anderson-Fabry disease, novel GLA mutation and severe cardiac phenotype","volume":"142","author":"San Rom\u00e1n-Monserrat","year":"2014","journal-title":"Med Cl\u00ednica"},{"key":"key\n\t\t\t\t20180914094344_eux261-B30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.beem.2014.10.003","article-title":"Fabry disease and the heart","volume":"29","author":"Seydelmann","year":"2015","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180914094344_eux261-B31","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jcmg.2011.01.020","article-title":"Differences in Fabry cardiomyopathy between female and male patients","volume":"4","author":"Niemann","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"key\n\t\t\t\t20180914094344_eux261-B32","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s10897-008-9179-7","article-title":"Disease rarity, carrier status, and gender: a triple disadvantage for women with Fabry disease","volume":"17","author":"Gibas","year":"2008","journal-title":"J Genet Couns"},{"key":"key\n\t\t\t\t20180914094344_eux261-B33","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa1510198","article-title":"Treatment of Fabry\u2019s disease with the pharmacologic chaperone migalastat","volume":"375","author":"Germain","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180914094344_eux261-B34","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jacc.2010.06.062","article-title":"Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death","volume":"57","author":"Iles","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180914094344_eux261-B35","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/eurheartj\/ehi143","article-title":"The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease","volume":"26","author":"Weidemann","year":"2005","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180914094344_eux261-B36","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.hrthm.2010.08.006","article-title":"Endocardial and epicardial substrates of ventricular tachycardia in a patient with Fabry disease","volume":"8","author":"Higashi","year":"2011","journal-title":"Heart Rhythm"},{"key":"key\n\t\t\t\t20180914094344_eux261-B37","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jacc.2009.05.032","article-title":"Electroanatomic substrate and ablation outcome for suspected epicardial ventricular tachycardia in left ventricular nonischemic cardiomyopathy","volume":"54","author":"Cano","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180914094344_eux261-B38","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.CIR.0000083725.72693.EA","article-title":"Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia","volume":"108","author":"Hsia","year":"2003","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180914094344_eux261-B39","doi-asserted-by":"crossref","first-page":"e002839.","DOI":"10.1161\/JAHA.115.002839","article-title":"High-sensitivity troponin: a clinical blood biomarker for staging cardiomyopathy in Fabry Disease","volume":"5","author":"Seydelmann","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"key\n\t\t\t\t20180914094344_eux261-B40","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.jacc.2016.07.741","article-title":"Cardiac Fabry disease with late gadolinium enhancement is a chronic inflammatory cardiomyopathy","volume":"68","author":"Nordin","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180914094344_eux261-B41","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1093\/europace\/eur267","article-title":"Incidence and predictors of anti-bradycardia pacing in patients with Anderson-Fabry disease","volume":"13","author":"O\u2019Mahony","year":"2011","journal-title":"Europace"},{"key":"key\n\t\t\t\t20180914094344_eux261-B42","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"K\u00f8ber","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180914094344_eux261-B43","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.ejheart.2008.07.002","article-title":"Non-sustained ventricular tachycardia as a predictor of sudden cardiac death in patients with left ventricular dysfunction: a meta-analysis","volume":"10","author":"de Sousa","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t20180914094344_eux261-B44","doi-asserted-by":"crossref","first-page":"e0160181.","DOI":"10.1371\/journal.pone.0160181","article-title":"Long-term outcome of non-sustained ventricular tachycardia in structurally normal hearts","volume":"11","author":"Lin","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180914094344_eux261-B45","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0735-1097(03)00827-1","article-title":"Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy","volume":"42","author":"Monserrat","year":"2003","journal-title":"J Am Coll Cardiol"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/20\/FI2\/f153\/25734676\/eux261.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T16:19:45Z","timestamp":1570205985000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/20\/FI2\/f153\/4555480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,17]]},"references-count":45,"journal-issue":{"issue":"FI2","published-online":{"date-parts":[[2017,10,17]]},"published-print":{"date-parts":[[2018,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/eux261","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,9]]},"published":{"date-parts":[[2017,10,17]]}}}